Generic placeholder image

Current Rheumatology Reviews

Author(s): Yi-Xi He, Quan-Bo Zhang, Fei Dai, Jian-Xiong Zheng and Yu-Feng Qing*

DOI: 10.2174/1573397119666230214104242

DownloadDownload PDF Flyer Cite As
Association of microRNA-146a rs57095329 Polymorphism with Susceptibility to Primary Gout in a Chinese Han Population

Page: [336 - 344] Pages: 9

  • * (Excluding Mailing and Handling)

Abstract

Background: MicroRNA-146a (miR-146a) plays a critical role in the regulation of autoinflammatory diseases, including gout. There is growing evidence that miR-146a gene single nucleotide polymorphisms (SNPs) are associated with different diseases, but no genetic relevance studies of miR-146a gene polymorphisms to gout have been reported by now.

Objective: The purpose of this study was to examine the relationship between the miR-146a rs57095329 genetic polymorphism and the susceptibility to primary gout in the Chinese Han population.

Methods: A case-control study was performed in this report to examine the potential association between gout and the functional rs57095329 SNP of miR-146a in a Chinese population consisting of 448 primary gout patients (containing 76 tophi patients) and 418 healthy controls. MiR-146a expression in peripheral blood mononuclear cells (PBMCs) was measured in 81 gout patients (including 32 tophi patients and 49 non-tophi patients) and 47 healthy subjects.

Results: There was no significant difference found in the distribution of miR-146a rs57095329 between 448 gout patients and 418 healthy subjects (P > 0.05). However, significant differences in genotypes and allele distributions were found between 76 gout with tophi patients and 418 healthy subjects, as well as between gout with tophi (76) and with no tophi patients (372) (P < 0.01, respectively). Gout patients with AG/GG genotypes had a 0.323-fold reduced risk for tophi than those with the AA genotype, and the G allele had a 0.362-fold reduced risk of tophi. Furthermore, in 32 tophi patients, the GG genotype was significantly associated with increased expression of miR- 146a.

Conclusion: Our findings suggest that rs57095329 may play a protective role in tophi gout susceptibility, and rs57095329 A > G variant may modulate the expression of miR-146a in tophi patients.

Graphical Abstract

[1]
Dalbeth N, Merriman TR, Stamp LK. Gout Lancet 2016; 388(10055): 2039-52.
[http://dx.doi.org/10.1016/S0140-6736(16)00346-9] [PMID: 27112094]
[2]
Dehlin M, Jacobsson L, Roddy E. Global epidemiology of gout: Prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol 2020; 16(7): 380-90.
[http://dx.doi.org/10.1038/s41584-020-0441-1] [PMID: 32541923]
[3]
Miao Z, Li C, Chen Y, et al. Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China. J Rheumatol 2008; 35(9): 1859-64.
[PMID: 18634142]
[4]
Annemans L, Spaepen E, Gaskin M, et al. Gout in the UK and Germany: Prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis 2008; 67(7): 960-6.
[http://dx.doi.org/10.1136/ard.2007.076232] [PMID: 17981913]
[5]
Qing YF, Zhang QB, Zhou JG. Innate immunity functional gene polymorphisms and gout susceptibility. Gene 2013; 524(2): 412-4.
[http://dx.doi.org/10.1016/j.gene.2013.04.039] [PMID: 23639963]
[6]
Bartel DP. MicroRNAs. Cell 2004; 116(2): 281-97.
[http://dx.doi.org/10.1016/S0092-8674(04)00045-5] [PMID: 14744438]
[7]
Yu HR, Huang LH, Li SC. Roles of microRNA in the immature immune system of neonates. Cancer Lett 2018; 433: 99-106.
[http://dx.doi.org/10.1016/j.canlet.2018.06.014] [PMID: 29908211]
[8]
Marschner D, Falk M, Javorniczky NR, et al. MicroRNA-146a regulates immune-related adverse events caused by immune checkpoint inhibitors. JCI Insight 2020; 5(6): e132334.
[http://dx.doi.org/10.1172/jci.insight.132334] [PMID: 32125286]
[9]
Zhou C, Zhao L, Wang K, et al. MicroRNA 146a inhibits NF κB activation and pro inflammatory cytokine production by regulating IRAK1 expression in THP 1 cells. Exp Ther Med 2019; 18(4): 3078-84.
[http://dx.doi.org/10.3892/etm.2019.7881] [PMID: 31572547]
[10]
Dalbeth N, Pool B, Shaw OM, et al. Role of miR-146a in regulation of the acute inflammatory response to monosodium urate crystals. Ann Rheum Dis 2015; 74(4): 786-90.
[http://dx.doi.org/10.1136/annrheumdis-2014-205409] [PMID: 25646371]
[11]
Zhang QB, Qing YF, Yin CC, et al. Mice with miR-146a deficiency develop severe gouty arthritis via dysregulation of TRAF 6, IRAK 1 and NALP3 inflammasome. Arthritis Res Ther 2018; 20(1): 45.
[http://dx.doi.org/10.1186/s13075-018-1546-7] [PMID: 29544526]
[12]
Luo X, Yang W, Ye DQ, et al. A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus. PLoS Genet 2011; 7(6): e1002128.
[http://dx.doi.org/10.1371/journal.pgen.1002128] [PMID: 21738483]
[13]
Keewan E, Naser SA. MiR-146a rs2910164 G > C polymorphism modulates Notch-1/IL-6 signaling during infection: A possible risk factor for Crohn’s disease. Gut Pathog 2020; 12: 48.
[http://dx.doi.org/10.1186/s13099-020-00387-0] [PMID: 33072191]
[14]
Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yü TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977; 20(3): 895-900.
[http://dx.doi.org/10.1002/art.1780200320] [PMID: 856219]
[15]
Neogi T, Jansen TL, Dalbeth N, et al. 2015 Gout classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2015; 67(10): 2557-68.
[http://dx.doi.org/10.1002/art.39254] [PMID: 26352873]
[16]
Qing YF, Zhou JG, Zhang QB, et al. Association of TLR4 Gene rs2149356 polymorphism with primary gouty arthritis in a casecontrol study. PLoS One 2013; 8(5): e64845.
[http://dx.doi.org/10.1371/journal.pone.0064845] [PMID: 23738004]
[17]
Qing YF, Zhou JG, Li M, et al. No evidence for involvement of the toll-like receptor (TLR) 4 gene Asp299Gly and Thr399Ile polymorphisms in susceptibility to primary gouty arthritis. Rheumatol Int 2013; 33(11): 2937-41.
[http://dx.doi.org/10.1007/s00296-012-2547-5] [PMID: 23152086]
[18]
He W, Phipps-Green A, Stamp LK, Merriman TR, Dalbeth N. Population-specific association between ABCG2 variants and tophaceous disease in people with gout. Arthritis Res Ther 2017; 19(1): 43.
[http://dx.doi.org/10.1186/s13075-017-1254-8] [PMID: 28270222]
[19]
Ma T, Liu X, Cen Z, et al. MicroRNA-302b negatively regulates IL-1β production in response to MSU crystals by targeting IRAK4 and EphA2. Arthritis Res Ther 2018; 20(1): 34.
[http://dx.doi.org/10.1186/s13075-018-1528-9] [PMID: 29482609]
[20]
Yang Q, Zhang Q, Qing Y, Zhou L, Mi Q, Zhou J. miR-155 is dispensable in monosodium urate-induced gouty inflammation in mice. Arthritis Res Ther 2018; 20(1): 144.
[http://dx.doi.org/10.1186/s13075-018-1550-y] [PMID: 29996893]
[21]
Zhou W, Wang Y, Wu R, He Y, Su Q, Shi G. MicroRNA-488 and -920 regulate the production of proinflammatory cytokines in acute gouty arthritis. Arthritis Res Ther 2017; 19(1): 203.
[http://dx.doi.org/10.1186/s13075-017-1418-6] [PMID: 28915828]
[22]
Boschiero MN, Camporeze B, Santos JSD, et al. The single nucleotide variant n.60G>C in the microRNA-146a associated with susceptibility to drug-resistant epilepsy. Epilepsy Res 2020; 162: 106305.
[http://dx.doi.org/10.1016/j.eplepsyres.2020.106305] [PMID: 32155539]
[23]
Li Y, Du C, Wang W, et al. Genetic association of MiR-146a with multiple sclerosis susceptibility in the Chinese population. Cell Physiol Biochem 2015; 35(1): 281-91.
[http://dx.doi.org/10.1159/000369695] [PMID: 25591770]
[24]
Abdelaleem OO, Fouad NA, Shaker OG, et al. Association of miR-146a rs57095329 with Behçet’s disease and its complications. Br J Biomed Sci 2021; 78(2): 63-6.
[http://dx.doi.org/10.1080/09674845.2020.1786284] [PMID: 32569501]
[25]
Zha L, Li S, Liu X, et al. Association of miR-146a Gene Polymorphism at loci rs2910164 G/C, rs57095329 A/G, and rs6864584 T/C with susceptibility to kawasaki disease in chinese children. Pediatr Cardiol 2019; 40(3): 504-12.
[http://dx.doi.org/10.1007/s00246-018-2002-9] [PMID: 30291383]
[26]
Cui L, Li Y, Ma G, et al. A functional polymorphism in the promoter region of microRNA-146a is associated with the risk of Alzheimer disease and the rate of cognitive decline in patients. PLoS One 2014; 9(2): e89019.
[http://dx.doi.org/10.1371/journal.pone.0089019] [PMID: 24586483]
[27]
Niu Z, Wang J, Zou H, Yang C, Huang W, Jin L. Common MIR146A polymorphisms in Chinese ankylosing spondylitis subjects and controls. PLoS One 2015; 10(9): e0137770.
[http://dx.doi.org/10.1371/journal.pone.0137770] [PMID: 26366721]
[28]
Park R, Lee WJ, Ji JD. Association between the three functional miR-146a single-nucleotide polymorphisms, rs2910164, rs57095329, and rs2431697, and autoimmune disease susceptibility: A meta-analysis. Autoimmunity 2016; 49(7): 451-8.
[http://dx.doi.org/10.3109/08916934.2016.1171854] [PMID: 27098222]
[29]
Towiwat P, Chhana A, Dalbeth N. The anatomical pathology of gout: A systematic literature review. BMC Musculoskelet Disord 2019; 20(1): 140.
[http://dx.doi.org/10.1186/s12891-019-2519-y] [PMID: 30935368]
[30]
Perez-Ruiz F, Martínez-Indart L, Carmona L, Herrero-Beites AM, Pijoan JI, Krishnan E. Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout. Ann Rheum Dis 2014; 73(1): 177-82.
[http://dx.doi.org/10.1136/annrheumdis-2012-202421] [PMID: 23313809]